Recurrent atrial arrhythmia

Disease1 paper1 finding

Human trial1

Associations

1

Metformin

downin humans1HR 0.5

1 study

Metformin lowers the risk of recurrent atrial arrhythmia in humans (HR: 0.5; 95% CI: 0.2-0.9; P = 0.04).
Human trialpatients undergoing AF ablation with BMI > 25 kg/m2 and without diabetes1 yearn = 99
Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation (META-AF) · JACC. Clinical electrophysiology · 15 Aug 2026

Latest

1

JACC Clinical ElectrophysiologyHuman trial28 Aug

Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation (META-AF)